ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Anti-schizophrenic Drugs Market Research Report 2025
Published Date: January 2025
|
Report Code: QYRE-Auto-5L11904
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Anti schizophrenic Drugs Market Research Report 2022
BUY CHAPTERS

Global Anti-schizophrenic Drugs Market Research Report 2025

Code: QYRE-Auto-5L11904
Report
January 2025
Pages:81
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Johnson & Johnson
Eli Lilly
Otsuka Pharmaceutical
Intra-Cellular Therapies
Sunovion Pharmaceuticals
Gedeon Richter
Alexza Pharmaceuticals
Noven Pharmaceuticals
Hisamitsu Pharmaceutical
Zhejiang Huahai
Chengdu Kanghong Pharmaceutical
Astrazeneca plc
Pfizer Inc
Alkermes plc

Anti-schizophrenic Drugs Market

The global market for Anti-schizophrenic Drugs was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Anti-schizophrenic Drugs is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Anti-schizophrenic Drugs is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Anti-schizophrenic Drugs in Hospitals is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Anti-schizophrenic Drugs include Pfizer, Johnson & Johnson, AstraZeneca, Eli Lilly, Otsuka Pharmaceutical, Intra-Cellular Therapies, Sunovion Pharmaceuticals, Gedeon Richter, Alkermes, Indivior, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Anti-schizophrenic Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-schizophrenic Drugs.
The Anti-schizophrenic Drugs market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Anti-schizophrenic Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Anti-schizophrenic Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Anti-schizophrenic Drugs Market Report

Report Metric Details
Report Name Anti-schizophrenic Drugs Market
Segment by Type
Segment by Application
  • Hospitals
  • Clinics
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Pfizer, Johnson & Johnson, AstraZeneca, Eli Lilly, Otsuka Pharmaceutical, Intra-Cellular Therapies, Sunovion Pharmaceuticals, Gedeon Richter, Alkermes, Indivior, Alexza Pharmaceuticals, Noven Pharmaceuticals, Hisamitsu Pharmaceutical, Zhejiang Huahai, Chengdu Kanghong Pharmaceutical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Anti-schizophrenic Drugs company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Anti-schizophrenic Drugs Market report?

Ans: The main players in the Anti-schizophrenic Drugs Market are Pfizer, Johnson & Johnson, AstraZeneca, Eli Lilly, Otsuka Pharmaceutical, Intra-Cellular Therapies, Sunovion Pharmaceuticals, Gedeon Richter, Alkermes, Indivior, Alexza Pharmaceuticals, Noven Pharmaceuticals, Hisamitsu Pharmaceutical, Zhejiang Huahai, Chengdu Kanghong Pharmaceutical

What are the Application segmentation covered in the Anti-schizophrenic Drugs Market report?

Ans: The Applications covered in the Anti-schizophrenic Drugs Market report are Hospitals, Clinics, Other

What are the Type segmentation covered in the Anti-schizophrenic Drugs Market report?

Ans: The Types covered in the Anti-schizophrenic Drugs Market report are Tablets, Capsules, Other

Recommended Reports

Psychiatric Drugs Markets

Neurodegenerative Disease Drugs

Other Therapeutic Drugs

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Anti-schizophrenic Drugs Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Tablets
1.2.3 Capsules
1.2.4 Other
1.3 Market by Application
1.3.1 Global Anti-schizophrenic Drugs Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Anti-schizophrenic Drugs Market Perspective (2020-2031)
2.2 Global Anti-schizophrenic Drugs Growth Trends by Region
2.2.1 Global Anti-schizophrenic Drugs Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Anti-schizophrenic Drugs Historic Market Size by Region (2020-2025)
2.2.3 Anti-schizophrenic Drugs Forecasted Market Size by Region (2026-2031)
2.3 Anti-schizophrenic Drugs Market Dynamics
2.3.1 Anti-schizophrenic Drugs Industry Trends
2.3.2 Anti-schizophrenic Drugs Market Drivers
2.3.3 Anti-schizophrenic Drugs Market Challenges
2.3.4 Anti-schizophrenic Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Anti-schizophrenic Drugs Players by Revenue
3.1.1 Global Top Anti-schizophrenic Drugs Players by Revenue (2020-2025)
3.1.2 Global Anti-schizophrenic Drugs Revenue Market Share by Players (2020-2025)
3.2 Global Anti-schizophrenic Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Anti-schizophrenic Drugs Revenue
3.4 Global Anti-schizophrenic Drugs Market Concentration Ratio
3.4.1 Global Anti-schizophrenic Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Anti-schizophrenic Drugs Revenue in 2024
3.5 Global Key Players of Anti-schizophrenic Drugs Head office and Area Served
3.6 Global Key Players of Anti-schizophrenic Drugs, Product and Application
3.7 Global Key Players of Anti-schizophrenic Drugs, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Anti-schizophrenic Drugs Breakdown Data by Type
4.1 Global Anti-schizophrenic Drugs Historic Market Size by Type (2020-2025)
4.2 Global Anti-schizophrenic Drugs Forecasted Market Size by Type (2026-2031)
5 Anti-schizophrenic Drugs Breakdown Data by Application
5.1 Global Anti-schizophrenic Drugs Historic Market Size by Application (2020-2025)
5.2 Global Anti-schizophrenic Drugs Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Anti-schizophrenic Drugs Market Size (2020-2031)
6.2 North America Anti-schizophrenic Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Anti-schizophrenic Drugs Market Size by Country (2020-2025)
6.4 North America Anti-schizophrenic Drugs Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Anti-schizophrenic Drugs Market Size (2020-2031)
7.2 Europe Anti-schizophrenic Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Anti-schizophrenic Drugs Market Size by Country (2020-2025)
7.4 Europe Anti-schizophrenic Drugs Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Anti-schizophrenic Drugs Market Size (2020-2031)
8.2 Asia-Pacific Anti-schizophrenic Drugs Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Anti-schizophrenic Drugs Market Size by Region (2020-2025)
8.4 Asia-Pacific Anti-schizophrenic Drugs Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Anti-schizophrenic Drugs Market Size (2020-2031)
9.2 Latin America Anti-schizophrenic Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Anti-schizophrenic Drugs Market Size by Country (2020-2025)
9.4 Latin America Anti-schizophrenic Drugs Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Anti-schizophrenic Drugs Market Size (2020-2031)
10.2 Middle East & Africa Anti-schizophrenic Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Anti-schizophrenic Drugs Market Size by Country (2020-2025)
10.4 Middle East & Africa Anti-schizophrenic Drugs Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Anti-schizophrenic Drugs Introduction
11.1.4 Pfizer Revenue in Anti-schizophrenic Drugs Business (2020-2025)
11.1.5 Pfizer Recent Development
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Company Details
11.2.2 Johnson & Johnson Business Overview
11.2.3 Johnson & Johnson Anti-schizophrenic Drugs Introduction
11.2.4 Johnson & Johnson Revenue in Anti-schizophrenic Drugs Business (2020-2025)
11.2.5 Johnson & Johnson Recent Development
11.3 AstraZeneca
11.3.1 AstraZeneca Company Details
11.3.2 AstraZeneca Business Overview
11.3.3 AstraZeneca Anti-schizophrenic Drugs Introduction
11.3.4 AstraZeneca Revenue in Anti-schizophrenic Drugs Business (2020-2025)
11.3.5 AstraZeneca Recent Development
11.4 Eli Lilly
11.4.1 Eli Lilly Company Details
11.4.2 Eli Lilly Business Overview
11.4.3 Eli Lilly Anti-schizophrenic Drugs Introduction
11.4.4 Eli Lilly Revenue in Anti-schizophrenic Drugs Business (2020-2025)
11.4.5 Eli Lilly Recent Development
11.5 Otsuka Pharmaceutical
11.5.1 Otsuka Pharmaceutical Company Details
11.5.2 Otsuka Pharmaceutical Business Overview
11.5.3 Otsuka Pharmaceutical Anti-schizophrenic Drugs Introduction
11.5.4 Otsuka Pharmaceutical Revenue in Anti-schizophrenic Drugs Business (2020-2025)
11.5.5 Otsuka Pharmaceutical Recent Development
11.6 Intra-Cellular Therapies
11.6.1 Intra-Cellular Therapies Company Details
11.6.2 Intra-Cellular Therapies Business Overview
11.6.3 Intra-Cellular Therapies Anti-schizophrenic Drugs Introduction
11.6.4 Intra-Cellular Therapies Revenue in Anti-schizophrenic Drugs Business (2020-2025)
11.6.5 Intra-Cellular Therapies Recent Development
11.7 Sunovion Pharmaceuticals
11.7.1 Sunovion Pharmaceuticals Company Details
11.7.2 Sunovion Pharmaceuticals Business Overview
11.7.3 Sunovion Pharmaceuticals Anti-schizophrenic Drugs Introduction
11.7.4 Sunovion Pharmaceuticals Revenue in Anti-schizophrenic Drugs Business (2020-2025)
11.7.5 Sunovion Pharmaceuticals Recent Development
11.8 Gedeon Richter
11.8.1 Gedeon Richter Company Details
11.8.2 Gedeon Richter Business Overview
11.8.3 Gedeon Richter Anti-schizophrenic Drugs Introduction
11.8.4 Gedeon Richter Revenue in Anti-schizophrenic Drugs Business (2020-2025)
11.8.5 Gedeon Richter Recent Development
11.9 Alkermes
11.9.1 Alkermes Company Details
11.9.2 Alkermes Business Overview
11.9.3 Alkermes Anti-schizophrenic Drugs Introduction
11.9.4 Alkermes Revenue in Anti-schizophrenic Drugs Business (2020-2025)
11.9.5 Alkermes Recent Development
11.10 Indivior
11.10.1 Indivior Company Details
11.10.2 Indivior Business Overview
11.10.3 Indivior Anti-schizophrenic Drugs Introduction
11.10.4 Indivior Revenue in Anti-schizophrenic Drugs Business (2020-2025)
11.10.5 Indivior Recent Development
11.11 Alexza Pharmaceuticals
11.11.1 Alexza Pharmaceuticals Company Details
11.11.2 Alexza Pharmaceuticals Business Overview
11.11.3 Alexza Pharmaceuticals Anti-schizophrenic Drugs Introduction
11.11.4 Alexza Pharmaceuticals Revenue in Anti-schizophrenic Drugs Business (2020-2025)
11.11.5 Alexza Pharmaceuticals Recent Development
11.12 Noven Pharmaceuticals
11.12.1 Noven Pharmaceuticals Company Details
11.12.2 Noven Pharmaceuticals Business Overview
11.12.3 Noven Pharmaceuticals Anti-schizophrenic Drugs Introduction
11.12.4 Noven Pharmaceuticals Revenue in Anti-schizophrenic Drugs Business (2020-2025)
11.12.5 Noven Pharmaceuticals Recent Development
11.13 Hisamitsu Pharmaceutical
11.13.1 Hisamitsu Pharmaceutical Company Details
11.13.2 Hisamitsu Pharmaceutical Business Overview
11.13.3 Hisamitsu Pharmaceutical Anti-schizophrenic Drugs Introduction
11.13.4 Hisamitsu Pharmaceutical Revenue in Anti-schizophrenic Drugs Business (2020-2025)
11.13.5 Hisamitsu Pharmaceutical Recent Development
11.14 Zhejiang Huahai
11.14.1 Zhejiang Huahai Company Details
11.14.2 Zhejiang Huahai Business Overview
11.14.3 Zhejiang Huahai Anti-schizophrenic Drugs Introduction
11.14.4 Zhejiang Huahai Revenue in Anti-schizophrenic Drugs Business (2020-2025)
11.14.5 Zhejiang Huahai Recent Development
11.15 Chengdu Kanghong Pharmaceutical
11.15.1 Chengdu Kanghong Pharmaceutical Company Details
11.15.2 Chengdu Kanghong Pharmaceutical Business Overview
11.15.3 Chengdu Kanghong Pharmaceutical Anti-schizophrenic Drugs Introduction
11.15.4 Chengdu Kanghong Pharmaceutical Revenue in Anti-schizophrenic Drugs Business (2020-2025)
11.15.5 Chengdu Kanghong Pharmaceutical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Johnson & Johnson
Eli Lilly
Otsuka Pharmaceutical
Intra-Cellular Therapies
Sunovion Pharmaceuticals
Gedeon Richter
Alexza Pharmaceuticals
Noven Pharmaceuticals
Hisamitsu Pharmaceutical
Zhejiang Huahai
Chengdu Kanghong Pharmaceutical
Astrazeneca plc
Pfizer Inc
Alkermes plc
List of Tables
 Table 1. Global Anti-schizophrenic Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Tablets
 Table 3. Key Players of Capsules
 Table 4. Key Players of Other
 Table 5. Global Anti-schizophrenic Drugs Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Anti-schizophrenic Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Anti-schizophrenic Drugs Market Size by Region (2020-2025) & (US$ Million)
 Table 8. Global Anti-schizophrenic Drugs Market Share by Region (2020-2025)
 Table 9. Global Anti-schizophrenic Drugs Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 10. Global Anti-schizophrenic Drugs Market Share by Region (2026-2031)
 Table 11. Anti-schizophrenic Drugs Market Trends
 Table 12. Anti-schizophrenic Drugs Market Drivers
 Table 13. Anti-schizophrenic Drugs Market Challenges
 Table 14. Anti-schizophrenic Drugs Market Restraints
 Table 15. Global Anti-schizophrenic Drugs Revenue by Players (2020-2025) & (US$ Million)
 Table 16. Global Anti-schizophrenic Drugs Market Share by Players (2020-2025)
 Table 17. Global Top Anti-schizophrenic Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-schizophrenic Drugs as of 2024)
 Table 18. Ranking of Global Top Anti-schizophrenic Drugs Companies by Revenue (US$ Million) in 2024
 Table 19. Global 5 Largest Players Market Share by Anti-schizophrenic Drugs Revenue (CR5 and HHI) & (2020-2025)
 Table 20. Global Key Players of Anti-schizophrenic Drugs, Headquarters and Area Served
 Table 21. Global Key Players of Anti-schizophrenic Drugs, Product and Application
 Table 22. Global Key Players of Anti-schizophrenic Drugs, Date of Enter into This Industry
 Table 23. Mergers & Acquisitions, Expansion Plans
 Table 24. Global Anti-schizophrenic Drugs Market Size by Type (2020-2025) & (US$ Million)
 Table 25. Global Anti-schizophrenic Drugs Revenue Market Share by Type (2020-2025)
 Table 26. Global Anti-schizophrenic Drugs Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 27. Global Anti-schizophrenic Drugs Revenue Market Share by Type (2026-2031)
 Table 28. Global Anti-schizophrenic Drugs Market Size by Application (2020-2025) & (US$ Million)
 Table 29. Global Anti-schizophrenic Drugs Revenue Market Share by Application (2020-2025)
 Table 30. Global Anti-schizophrenic Drugs Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 31. Global Anti-schizophrenic Drugs Revenue Market Share by Application (2026-2031)
 Table 32. North America Anti-schizophrenic Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 33. North America Anti-schizophrenic Drugs Market Size by Country (2020-2025) & (US$ Million)
 Table 34. North America Anti-schizophrenic Drugs Market Size by Country (2026-2031) & (US$ Million)
 Table 35. Europe Anti-schizophrenic Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 36. Europe Anti-schizophrenic Drugs Market Size by Country (2020-2025) & (US$ Million)
 Table 37. Europe Anti-schizophrenic Drugs Market Size by Country (2026-2031) & (US$ Million)
 Table 38. Asia-Pacific Anti-schizophrenic Drugs Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 39. Asia-Pacific Anti-schizophrenic Drugs Market Size by Region (2020-2025) & (US$ Million)
 Table 40. Asia-Pacific Anti-schizophrenic Drugs Market Size by Region (2026-2031) & (US$ Million)
 Table 41. Latin America Anti-schizophrenic Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 42. Latin America Anti-schizophrenic Drugs Market Size by Country (2020-2025) & (US$ Million)
 Table 43. Latin America Anti-schizophrenic Drugs Market Size by Country (2026-2031) & (US$ Million)
 Table 44. Middle East & Africa Anti-schizophrenic Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 45. Middle East & Africa Anti-schizophrenic Drugs Market Size by Country (2020-2025) & (US$ Million)
 Table 46. Middle East & Africa Anti-schizophrenic Drugs Market Size by Country (2026-2031) & (US$ Million)
 Table 47. Pfizer Company Details
 Table 48. Pfizer Business Overview
 Table 49. Pfizer Anti-schizophrenic Drugs Product
 Table 50. Pfizer Revenue in Anti-schizophrenic Drugs Business (2020-2025) & (US$ Million)
 Table 51. Pfizer Recent Development
 Table 52. Johnson & Johnson Company Details
 Table 53. Johnson & Johnson Business Overview
 Table 54. Johnson & Johnson Anti-schizophrenic Drugs Product
 Table 55. Johnson & Johnson Revenue in Anti-schizophrenic Drugs Business (2020-2025) & (US$ Million)
 Table 56. Johnson & Johnson Recent Development
 Table 57. AstraZeneca Company Details
 Table 58. AstraZeneca Business Overview
 Table 59. AstraZeneca Anti-schizophrenic Drugs Product
 Table 60. AstraZeneca Revenue in Anti-schizophrenic Drugs Business (2020-2025) & (US$ Million)
 Table 61. AstraZeneca Recent Development
 Table 62. Eli Lilly Company Details
 Table 63. Eli Lilly Business Overview
 Table 64. Eli Lilly Anti-schizophrenic Drugs Product
 Table 65. Eli Lilly Revenue in Anti-schizophrenic Drugs Business (2020-2025) & (US$ Million)
 Table 66. Eli Lilly Recent Development
 Table 67. Otsuka Pharmaceutical Company Details
 Table 68. Otsuka Pharmaceutical Business Overview
 Table 69. Otsuka Pharmaceutical Anti-schizophrenic Drugs Product
 Table 70. Otsuka Pharmaceutical Revenue in Anti-schizophrenic Drugs Business (2020-2025) & (US$ Million)
 Table 71. Otsuka Pharmaceutical Recent Development
 Table 72. Intra-Cellular Therapies Company Details
 Table 73. Intra-Cellular Therapies Business Overview
 Table 74. Intra-Cellular Therapies Anti-schizophrenic Drugs Product
 Table 75. Intra-Cellular Therapies Revenue in Anti-schizophrenic Drugs Business (2020-2025) & (US$ Million)
 Table 76. Intra-Cellular Therapies Recent Development
 Table 77. Sunovion Pharmaceuticals Company Details
 Table 78. Sunovion Pharmaceuticals Business Overview
 Table 79. Sunovion Pharmaceuticals Anti-schizophrenic Drugs Product
 Table 80. Sunovion Pharmaceuticals Revenue in Anti-schizophrenic Drugs Business (2020-2025) & (US$ Million)
 Table 81. Sunovion Pharmaceuticals Recent Development
 Table 82. Gedeon Richter Company Details
 Table 83. Gedeon Richter Business Overview
 Table 84. Gedeon Richter Anti-schizophrenic Drugs Product
 Table 85. Gedeon Richter Revenue in Anti-schizophrenic Drugs Business (2020-2025) & (US$ Million)
 Table 86. Gedeon Richter Recent Development
 Table 87. Alkermes Company Details
 Table 88. Alkermes Business Overview
 Table 89. Alkermes Anti-schizophrenic Drugs Product
 Table 90. Alkermes Revenue in Anti-schizophrenic Drugs Business (2020-2025) & (US$ Million)
 Table 91. Alkermes Recent Development
 Table 92. Indivior Company Details
 Table 93. Indivior Business Overview
 Table 94. Indivior Anti-schizophrenic Drugs Product
 Table 95. Indivior Revenue in Anti-schizophrenic Drugs Business (2020-2025) & (US$ Million)
 Table 96. Indivior Recent Development
 Table 97. Alexza Pharmaceuticals Company Details
 Table 98. Alexza Pharmaceuticals Business Overview
 Table 99. Alexza Pharmaceuticals Anti-schizophrenic Drugs Product
 Table 100. Alexza Pharmaceuticals Revenue in Anti-schizophrenic Drugs Business (2020-2025) & (US$ Million)
 Table 101. Alexza Pharmaceuticals Recent Development
 Table 102. Noven Pharmaceuticals Company Details
 Table 103. Noven Pharmaceuticals Business Overview
 Table 104. Noven Pharmaceuticals Anti-schizophrenic Drugs Product
 Table 105. Noven Pharmaceuticals Revenue in Anti-schizophrenic Drugs Business (2020-2025) & (US$ Million)
 Table 106. Noven Pharmaceuticals Recent Development
 Table 107. Hisamitsu Pharmaceutical Company Details
 Table 108. Hisamitsu Pharmaceutical Business Overview
 Table 109. Hisamitsu Pharmaceutical Anti-schizophrenic Drugs Product
 Table 110. Hisamitsu Pharmaceutical Revenue in Anti-schizophrenic Drugs Business (2020-2025) & (US$ Million)
 Table 111. Hisamitsu Pharmaceutical Recent Development
 Table 112. Zhejiang Huahai Company Details
 Table 113. Zhejiang Huahai Business Overview
 Table 114. Zhejiang Huahai Anti-schizophrenic Drugs Product
 Table 115. Zhejiang Huahai Revenue in Anti-schizophrenic Drugs Business (2020-2025) & (US$ Million)
 Table 116. Zhejiang Huahai Recent Development
 Table 117. Chengdu Kanghong Pharmaceutical Company Details
 Table 118. Chengdu Kanghong Pharmaceutical Business Overview
 Table 119. Chengdu Kanghong Pharmaceutical Anti-schizophrenic Drugs Product
 Table 120. Chengdu Kanghong Pharmaceutical Revenue in Anti-schizophrenic Drugs Business (2020-2025) & (US$ Million)
 Table 121. Chengdu Kanghong Pharmaceutical Recent Development
 Table 122. Research Programs/Design for This Report
 Table 123. Key Data Information from Secondary Sources
 Table 124. Key Data Information from Primary Sources
 Table 125. Authors List of This Report


List of Figures
 Figure 1. Anti-schizophrenic Drugs Picture
 Figure 2. Global Anti-schizophrenic Drugs Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Anti-schizophrenic Drugs Market Share by Type: 2024 VS 2031
 Figure 4. Tablets Features
 Figure 5. Capsules Features
 Figure 6. Other Features
 Figure 7. Global Anti-schizophrenic Drugs Market Size by Application (2020-2031) & (US$ Million)
 Figure 8. Global Anti-schizophrenic Drugs Market Share by Application: 2024 VS 2031
 Figure 9. Hospitals Case Studies
 Figure 10. Clinics Case Studies
 Figure 11. Other Case Studies
 Figure 12. Anti-schizophrenic Drugs Report Years Considered
 Figure 13. Global Anti-schizophrenic Drugs Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 14. Global Anti-schizophrenic Drugs Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Anti-schizophrenic Drugs Market Share by Region: 2024 VS 2031
 Figure 16. Global Anti-schizophrenic Drugs Market Share by Players in 2024
 Figure 17. Global Top Anti-schizophrenic Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-schizophrenic Drugs as of 2024)
 Figure 18. The Top 10 and 5 Players Market Share by Anti-schizophrenic Drugs Revenue in 2024
 Figure 19. North America Anti-schizophrenic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 20. North America Anti-schizophrenic Drugs Market Share by Country (2020-2031)
 Figure 21. United States Anti-schizophrenic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Canada Anti-schizophrenic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe Anti-schizophrenic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Anti-schizophrenic Drugs Market Share by Country (2020-2031)
 Figure 25. Germany Anti-schizophrenic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. France Anti-schizophrenic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. U.K. Anti-schizophrenic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Italy Anti-schizophrenic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Russia Anti-schizophrenic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Nordic Countries Anti-schizophrenic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Asia-Pacific Anti-schizophrenic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Anti-schizophrenic Drugs Market Share by Region (2020-2031)
 Figure 33. China Anti-schizophrenic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Japan Anti-schizophrenic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. South Korea Anti-schizophrenic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Southeast Asia Anti-schizophrenic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. India Anti-schizophrenic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Australia Anti-schizophrenic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Latin America Anti-schizophrenic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Anti-schizophrenic Drugs Market Share by Country (2020-2031)
 Figure 41. Mexico Anti-schizophrenic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Brazil Anti-schizophrenic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Middle East & Africa Anti-schizophrenic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Anti-schizophrenic Drugs Market Share by Country (2020-2031)
 Figure 45. Turkey Anti-schizophrenic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Saudi Arabia Anti-schizophrenic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. UAE Anti-schizophrenic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Pfizer Revenue Growth Rate in Anti-schizophrenic Drugs Business (2020-2025)
 Figure 49. Johnson & Johnson Revenue Growth Rate in Anti-schizophrenic Drugs Business (2020-2025)
 Figure 50. AstraZeneca Revenue Growth Rate in Anti-schizophrenic Drugs Business (2020-2025)
 Figure 51. Eli Lilly Revenue Growth Rate in Anti-schizophrenic Drugs Business (2020-2025)
 Figure 52. Otsuka Pharmaceutical Revenue Growth Rate in Anti-schizophrenic Drugs Business (2020-2025)
 Figure 53. Intra-Cellular Therapies Revenue Growth Rate in Anti-schizophrenic Drugs Business (2020-2025)
 Figure 54. Sunovion Pharmaceuticals Revenue Growth Rate in Anti-schizophrenic Drugs Business (2020-2025)
 Figure 55. Gedeon Richter Revenue Growth Rate in Anti-schizophrenic Drugs Business (2020-2025)
 Figure 56. Alkermes Revenue Growth Rate in Anti-schizophrenic Drugs Business (2020-2025)
 Figure 57. Indivior Revenue Growth Rate in Anti-schizophrenic Drugs Business (2020-2025)
 Figure 58. Alexza Pharmaceuticals Revenue Growth Rate in Anti-schizophrenic Drugs Business (2020-2025)
 Figure 59. Noven Pharmaceuticals Revenue Growth Rate in Anti-schizophrenic Drugs Business (2020-2025)
 Figure 60. Hisamitsu Pharmaceutical Revenue Growth Rate in Anti-schizophrenic Drugs Business (2020-2025)
 Figure 61. Zhejiang Huahai Revenue Growth Rate in Anti-schizophrenic Drugs Business (2020-2025)
 Figure 62. Chengdu Kanghong Pharmaceutical Revenue Growth Rate in Anti-schizophrenic Drugs Business (2020-2025)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Novocure

SIMILAR REPORTS

Global Antipsychotic Medications Market Research Report 2024
Global Antipsychotic Drug Market Research Report 2024
Global Phenothiazine Market Research Report 2024
Antipsychotics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Aripiprazole Market Research Report 2025
Neuroleptics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Haloperidol Market Research Report 2024
Psychiatric Medications Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Psychiatric Medication Therapies Market Research Report 2024
Global Quetiapine Market Research Report 2025
Mental Disorders Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Antiglaucoma Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Long Acting Schizophrenia Drug Market Research Report 2024
Global Long acting Antipsychotic Market Research Report 2024
Global Atypical Antipsychotic Drugs Market Insights Forecast to 2030
Global Schizophrenia Related Peptide Market Research Report 2024
Global Ziprasidone HCl Market Research Report 2025
Global Psychiatric Long acting Injection Market Research Report 2024
Drugs for Treating Mental Disorders Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Anticonvulsant Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions